-+ 0.00%
-+ 0.00%
-+ 0.00%

VERRICA PHARMACEUTICALS: CO EXPECTS TO INITIATE SECOND PHASE 3 STUDY OF YCANTH IN US, JAPAN WITH TORII PHARMACEUTICAL IN MID-2026

Reuters·03/11/2026 12:00:05

Please log in to view news